Check where you can access Our Future Health data

Researchers can access Our Future Health data from many countries and territories.

Before you apply to become a researcher with us, check whether you can access Our Future Health data from each country or territory where you plan to work.

This access requirement is part of our eligible organisations policy (PDF only, 217 KB)

What the data access statuses mean

  • Accepted: You can access Our Future Health data from this country or territory.
  • Not accepted: You cannot access Our Future Health data from this country or territory. If you only plan to access the data from countries or territories listed as Not accepted, please do not submit a researcher application. We will not be able to give you access to the data. If you plan to access the data from both Accepted and Not accepted countries or territories, you can still apply. Our team will review your application.
  • Under review: We’re reviewing whether you can access Our Future Health data from this country or territory. You can still apply while we complete our review.
  • Not listed: We have not yet reviewed this country or territory. You can still apply and we’ll review whether you can access the data from there.
  • Requires review by NHS England: You can access Our Future Health data from this country or territory. If your study also requests NHS England data, NHS England will need to complete a separate review before you can access their data.

You can check this page again in the future to see if the status has changed.

Information:

If a country or territory is Accepted but does not have an adequacy decision, you’ll need an International Data Transfer Agreement (IDTA). Find the guide to International Transfers (opens in new tab)

Countries with partial adequacy in place

Canada

Partial adequacy - only covers data that is subject to Canada's Personal Information Protection and Electronic Documents Act (PIPEDA). Not all data is subject to PIPEDA. ICO guidance states that an adequacy decision in place if data is processed in the course of ‘commercial activity’. Institutions should consider whether they consider themselves subject to the Canadian Personal Information Protection and Electronic Documents Act (PIPEDA) regarding their access to TRE data. Please read the guidance on the scope of PIPEDA from the Office of the Privacy Commissioner of Canada for further information.

Japan

Partial adequacy - only covers personal data transferred to private sector organisations subject to Japan’s Act on the Protection of Personal Information. This does not include transfers of the types listed in the EU’s adequacy decision for Japan.

United States of America

Partial adequacy - only covers data which is transferred under the UK Extension to the EU-US Data Privacy Framework. You can find more information about the UK Extension, including a factsheet for UK organisations, on gov.uk and on the US Department of Commerce’s Data Privacy Framework Program website.

Check the status of every country or territory where you plan to access the data

Country

Data access status
Our Future Health

Data access status
NHS England

Adequacy decision

Afghanistan

Not accepted

N/A

N/A

Andorra

Accepted

Accepted

European Commission’s adequacy decision

Australia

Accepted

Accepted

None – IDTA required

Austria

Accepted

Accepted

EEA (EU)

Argentina

Accepted

Accepted

European Commission’s adequacy decision

Belarus

Not accepted

N/A

N/A

Belgium

Accepted

Accepted

EEA (EU)

Bosnia and Herzegovina

Not accepted

N/A

N/A

Bulgaria

Accepted

Accepted

EEA (EU)

Burundi

Not accepted

N/A

N/A

Canada

Accepted

Accepted

IDTA may be required

Central African Republic

Not accepted

N/A

N/A

China, People’s Republic of (including Macau)

Not accepted

N/A

N/A

Congo, Democratic Republic of

Not accepted

N/A

N/A

Crimea, Autonomous Republic of (Crimea Region of Ukraine)

Not accepted

N/A

N/A

Croatia

Accepted

Accepted

EEA (EU)

Cuba

Not accepted

N/A

N/A

Cyprus

Accepted

Accepted

EEA (EU)

Czech Republic

Accepted

Accepted

EEA (EU)

Denmark

Accepted

Accepted

EEA (EU)

Egypt

Accepted

Requires review by NHS England

None - IDTA required

Estonia

Accepted

Accepted

EEA (EU)

EU or EEA institutions, bodies, offices, or agencies

Accepted

Accepted

EEA

Faroe Islands

Accepted

Accepted

European Commission’s adequacy decision

Finland

Accepted

Accepted

EEA (EU)

France

Accepted

Accepted

EEA (EU)

Germany

Accepted

Accepted

EEA (EU)

Gibraltar

Accepted

Accepted

UK adequacy decision

Greece

Accepted

Accepted

EEA

Guernsey

Accepted

Accepted

European Commission’s adequacy decision

Guinea, Republic of

Not accepted

N/A

N/A

Guinea-Bissau, Republic of

Not accepted

N/A

N/A

Haiti

Not accepted

N/A

N/A

Hong Kong

Not accepted

N/A

N/A

Hungary

Accepted

Accepted

EEA (EU)

Iceland

Accepted

Accepted

EEA (EFTA)

Iran

Not accepted

N/A

N/A

Iraq

Not accepted

N/A

N/A

Ireland

Accepted

Accepted

EEA (EU)

Isle of Man

Accepted

Accepted

European Commission’s adequacy decision

Israel

Accepted

Accepted

European Commission’s adequacy decision

Italy

Accepted

Accepted

EEA (EU)

Japan

Accepted

Accepted

IDTA may be required

Jersey

Accepted

Accepted

European Commission’s adequacy decision

Kenya

Accepted

Accepted

None – IDTA required

Korea, Democratic People’s Republic of (North Korea)

Not accepted

N/A

N/A

Korea, Republic of (South Korea)

Accepted

Accepted

UK adequacy decision

Latvia

Accepted

Accepted

EEA (EU)

Lebanon

Not accepted

N/A

N/A

Libya

Not accepted

N/A

N/A

Liechtenstein

Accepted

Accepted

EEA (EFTA)

Lithuania

Accepted

Accepted

EEA (EU)

Luxembourg

Accepted

Accepted

EEA (EU)

Mali

Not accepted

N/A

N/A

Malta

Accepted

Accepted

EEA (EU)

Moldova

Not accepted

N/A

N/A

Myanmar, Republic of the Union of

Not accepted

N/A

N/A

Netherlands

Accepted

Accepted

EEA (EU)

New Zealand

Accepted

Accepted

European Commission’s adequacy decision

Nicaragua

Not accepted

N/A

N/A

Norway

Accepted

Accepted

EEA (EFTA)

Poland

Accepted

Accepted

EEA (EU)

Portugal

Accepted

Accepted

EEA (EU)

Romania

Accepted

Accepted

EEA (EU)

Russia

Not accepted

N/A

N/A

Slovakia

Accepted

Accepted

EEA (EU)

Slovenia

Accepted

Accepted

EEA (EU)

Somalia

Not accepted

N/A

N/A

South Sudan

Not accepted

N/A

N/A

Spain

Accepted

Accepted

EEA (EU)

Sudan

Not accepted

N/A

N/A

Sweden

Accepted

Accepted

EEA (EU)

Switzerland

Accepted

Accepted

European Commission’s adequacy decision

Syria

Not accepted

N/A

N/A

Taiwan

Not accepted

N/A

N/A

Turkey

Accepted

Requires review by NHS England

None - IDTA required

Ukraine

Not accepted

N/A

N/A

Uruguay

Accepted

Accepted

European Commission’s adequacy decision

United Arab Emirates

Not accepted

N/A

N/A

United States of America

Accepted

Accepted

IDTA may be required

Venezuela

Not accepted

N/A

N/A

Yemen

Not accepted

N/A

N/A

Zimbabwe

Not accepted

N/A

N/A

Updated: 13 October 2026